Tensile forces regulate epithelial homeostasis, but the molecular mechanisms behind this regulation are poorly understood. Using structured illumination microscopy and proximity ligation assays, we show that the tight junction protein ZO-1 exists in stretched and folded conformations within epithelial cells, depending on actomyosin-generated force. We also show that ZO-1 and ZO-2 regulate the localization of the transcription factor DbpA and the tight junction membrane protein occludin in a manner that depends on the organization of the actin cytoskeleton, myosin-II activity, and substrate stiffness, resulting in modulation of gene expression, cell proliferation, barrier function, and cyst morphogenesis. Pull-down experiments show that interactions between N-terminal (ZPSG) and C-terminal domains of ZO-1 prevent binding of DbpA to the ZPSG, suggesting that force-dependent intra-molecular interactions regulate ZPSG binding to ligands within cells. In vivo and in vitro experiments also suggest that ZO-1 heterodimerization with ZO-2 promotes the stretched conformation and ZPSG interaction with ligands. Magnetic tweezers single-molecule experiments suggest that pN-scale tensions ($2-4 pN) are sufficient to maintain the stretched conformation of ZO-1, while keeping its structured domains intact, and that 5-20 pN force is required to disrupt the interaction between the extreme C-terminal and the ZPSG domains of ZO-1. We propose that tensile forces regulate epithelial homeostasis by activating ZO proteins through stretching, to control the junctional recruitment and downstream signaling of their interactors.
INTRODUCTION
Extrinsic and intrinsic forces control the conformation of mechanosensing proteins at cadherin-and integrin-based junctions, regulating their association with the actin cytoskeleton and the strength of adhesion; however, little is known about how force regulates homeostasis, proliferation, and morphogenesis [1, 2] . Cytoplasmic actomyosin controls the nuclear shuttling of transcription factors [3] , and junctional actomyosin affects tight junction (TJ) barrier function [4-8], but it is not known whether any TJ protein can respond to tension by changing its conformation and how this may affect proteins involved in barrier function and signaling to the nucleus.
ZO-1 and ZO-2 (Zonula Occludens-1 and -2) [9, 10] are cytoplasmic TJ proteins, which anchor actin filaments to membrane proteins through their C-terminal regions [11, 12] . The C-terminal half of ZO-1 comprises actin-binding and ZU5 domains [13] and, when exogenously expressed, does not localize at junctions but in the cytoplasm, associated with actin filaments [11, 12, 14] . The N-terminal half of ZO-1 comprises three PDZ domains, followed by Src homology-3 (SH3), unique-5 (U5), guanylate kinase (GUK), and unique-6 (U6) domains [15, 16] . The PDZ1 and PDZ3 domains bind to the TJ membrane proteins claudins and JAM [17, 18] , and the PDZ2 domain promotes heterodimerization between ZO-1 and either ZO-2 or ZO-3, another member of the ZO family of proteins [11, 19, 20] , which is not expressed in Eph4 epithelial cells [21] . The region of ZO-1 comprising PDZ3, SH3, U5, and GUK domains (ZPSG-1) interacts with and recruits to junctions the transmembrane TJ protein occludin [11, 22] , the Y-box transcription factor DbpA/ZONAB (DNA-binding protein A/ZO-1-associated Nucleic Acid Binding protein) [23, 24] , and other ligands [13] . ZO-2 is also critical for the junctional recruitment and function of occludin [25, 26] . DbpA regulates gene expression and cell proliferation, and its sequestration by ZO-1 and ZO-2 at junctions of confluent monolayers inhibits its nuclear activity [23, 24, 27, 28] . Occludin is implicated in the regulation of TJ barrier function [29] [30] [31] , although occludin knockout mice have normal TJ [32] . Because ZO-1 and ZO-2 link TJ membrane proteins to actin filaments, we hypothesized that their conformation and downstream interactions and signaling might be modulated by force. Here, we show that ZO-1 exists in different force-dependent conformations and that the organization and contractility of the actomyosin cytoskeleton control the ability of ZO-1 and ZO-2 to recruit to junctions DbpA and occludin, to modulate gene expression, cell proliferation, barrier function, and epithelial morphogenesis.
RESULTS

Structured Illumination Microscopy and Proximity Ligation Assay Demonstrate Tension-Dependent Changes in ZO-1 Conformation within Cells
To test whether force controls ZO-1 conformation, we expressed ZO-1 tagged with myc and hemagglutinin (HA) at its N-terminal and C-terminal ends ( Figure 1A ) in ZO-1-KO (knockout) epithelial (Eph4) cells. Structured illumination microscopy (SIM) and proximity ligation assay (PLA) were used to examine the global spatial relationships between the ends of ZO-1 either in control cells or in cells depleted of ZO-2, with or without treatment with blebbistatin, which inhibits myosin-II activity. Exogenous ZO-1 was targeted to junctions and was detectable in the cytoplasm only in overexpressing cells (Figures S1A and S1B). A shift in the distribution of signal corresponding to myc and HA was detected in cells treated with a control small interfering RNA (siRNA), regardless of the absence ( Figure 1B ) or the presence ( Figure 1C ) of blebbistatin, and in cells depleted of ZO-2 and not treated with blebbistatin ( Figure 1D ), indicating a spatial separation between the ends of ZO-1. In contrast, depletion of ZO-2 plus blebbistatin treatment resulted in overlapped myc and HA signals ( Figure 1E ). Imaging of multicolor beads showed negligible chromatic shift (Figures 1F-1F'' and S1C), excluding the possibility that the shift between the two ZO-1 tags reflects spherical aberrations. In junctions between two cells expressing tagged ZO-1, a central myc-(N-terminal)-labeled region was flanked by two HA-(C-terminal)-labeled regions ( Figure 1G ), corresponding to a mirrorlike arrangement of ZO-1 molecules on the two sides. The ends of tagged cingulin, which contains a z130-nm-long domain [33] , were also imaged as separate ( Figures S1D-S1F ). Plotting the intensity of the signals as a function of the linear distance across the junction indicated a shift of z75 nm between the peaks of green and red fluorophores of ZO-1 when the signals were separated and z1 nm when they overlapped ( Figures 1H and 1I ). When measured across the two sides of a junction, the distance between the green fluorophores was z200 nm ( Figure S1G ).
Next, we examined tension-dependent changes in ZO-1 conformation using the PLA assay ( Figures 1J and 1K ). Little or no PLA signal was generated by myc and HA in the absence Figure S1 shows experimental system, control experiments, and additional measures and quantifications. Related Figure S7 shows schemes of ZO-1 in stretched and folded conformations under the different experimental conditions. of blebbistatin, regardless of the presence/depletion of ZO-2 (arrowheads, Figure 1J ), indicating that the N-terminal and C-terminal regions of ZO-1 are >30-40 nm apart, and no headto-tail aggregation of ZO-1 occurs. In contrast, in the presence of blebbistatin, the PLA signal was dramatically increased upon depletion of ZO-2 and was detectable both at junctions and in the cytoplasm of overexpressing cells (arrows, Figure 1K ; quantification, Figures S1H and S1I). This indicates that depletion of ZO-2 and low tension promote the proximity (<30-40 nm) between the ends of ZO-1.
The Mechanical Stability of Full-Length ZO-1 In Vitro To probe the mechanical stability of ZO-1, we applied force to purified recombinant full-length single molecules using magnetic tweezers [34, 35] (Figure 2A ). When force was linearly increased (loading rate 1 pN/s), the domains of ZO-1 were mechanically unfolded at forces of 5-60 pN, as indicated by multiple extension steps ( Figures 2B, S2A , S2C, S2E, and S2G-S2I). The unfolded domains of ZO-1 could be refolded at forces <5 pN (loading rate À0.1 pN/s; Figures 2C, 2D , S2B, S2D, and S2F). The distribution of unfolding forces shows that the majority of the domains unfold at 5-25 pN ( Figure 2D ). For each unfolding event, the number of residues of the unfolding domain (E) Distribution of number of residues involved in the individual unfolding events (N, number of unfolding events). The inset shows the distribution of total number of residues involved in unfolding in individual force-increase scans (N, number of scans). (F) Theoretical calculation of the force-extension curves of full-length ZO-1. Numbers of residues assumed to be non-structured are indicated. Related Figure S2 shows additional extension/ refolding curves and step size measurements.
can be estimated based on the step size. This was mainly in the range of 50-200 aa ( Figure 2E ), consistent with the number of residues in the structured domains of ZO-1 ( Figure S2J ). Furthermore, the estimated total number of residues ($600-900 residues) involved in the unfolding events spans 35%-50% of the full-length ZO-1 sequence ( Figure 2E , inset), most likely within the N-terminal half of ZO-1, which contains most ($500 aa) of the known structured domains ( Figure S2J ). The rest of the molecule, most likely the C-terminal half of the molecule, might be either in an intrinsically disordered conformation or mechanically too weak to be determined experimentally. Based on an assumption that the fraction ($50%-65%) of ZO-1 that does not give detectable unfolding events exists in a disordered conformation, we estimate that a force of $2-4 pN is needed to maintain the stretched conformation of ZO-1 ( Figure 2F) , with an N-to-C distance of $75 nm ( Figures 1H and 1I ). This force is smaller than that needed to unfold the structured domains (>5 pN; Figures 2B-2D ) and in the range of refolding forces (<5 pN; Figure 2C ). Interestingly, occasionally large extension jumps involving >500 residues were observed ( Figures 2E and S2E ), which might be related to intra-molecular interactions between distal regions of ZO-1.
The Stretched Conformation of ZO Proteins Promotes the Junctional Localization of DbpA and Occludin In Vivo Next, we asked how the stretched versus folded and/or disordered conformations of ZO-1 affected the junctional accumulation of DbpA ( Figure 3 ) and occludin ( Figure S3 ). In wild-type (WT) cells in the absence of blebbistatin, DbpA was detected at junctions regardless of the presence/depletion of ZO-2 ( Figures 3A and 3C ) [24] . However, upon blebbistatin treatment, DbpA labeling was reduced at junctions of ZO-2-depleted, but not WT cells ( Figures 3B and 3C ). DbpA levels were reduced in cells depleted of ZO-2 and treated with blebbistatin (red box, Figure 3D ), similar to ZO-1-KO cells depleted of ZO-2 [24] . Junctional labeling for occludin was normal in WT and ZO-2-KD (knockdown) cells in the absence of blebbistatin ( Figure S3A ) but was dramatically reduced by blebbistatin only in ZO-2-KD cells ( Figure S3B ).
Because DbpA and occludin interact with both ZO-1 and ZO-2 [11, 22, 24] , we used ZO-1-KO cells to ask whether tension affects not only ZO-1-but also ZO-2-dependent junctional accumulation of DbpA and occludin. In addition, we tested drugs that affect the organization of the actin cytoskeleton by treating mixed cultures of WT and ZO-1-KO cells with either latrunculin A, which prevents the polymerization of actin filaments; CK-869, which inhibits Arp2/3-dependent nucleation of branched actin filaments; SMIFH2, which inhibits the formin-dependent nucleation of bundled actin filaments ( Figure 3E ); and blebbistatin ( Figure 3F ). DbpA was localized at junctions of ZO-1-KO cells without any drug (arrows, Figure 3E , control), consistent with the notion that ZO-2 alone, in the absence of ZO-1, can sequester DbpA at junctions of confluent cells [24] . However, upon treatment with drugs that inhibit actin filament polymerization, DbpA was undetectable at junctions of ZO-1-KO, but not WT cells (arrowheads, Figure 3E ). Similarly, treatment of mixed WT/ZO-1-KO cells with blebbistatin induced loss of junctional DbpA only in cells expressing one ZO protein, but not in WT cells (arrowheads, Figure 3F , BL). Similar to what was observed upon depletion of both ZO proteins [24] , DbpA protein levels were decreased in ZO-1-KO cells treated with blebbistatin and normal DbpA levels were rescued by treatment with the proteasome inhibitor MG132 ( Figures 3G and 3H ), leading to detection of DbpA in the cytoplasm and nucleus of ZO-1 KO cells (''n,'' panel BL/MG, Figure 3F ). Occludin was also localized at junctions of both WT and ZO-1-KO cells (arrows in Figure S3C , control), but, upon treatment with blebbistatin, occludin labeling was decreased at junctions of ZO-1-KO, but not WT cells (arrowhead, Figure S3C , BL). PLA, used to detect proximity between ZO-1 and occludin, confirmed that, without blebbistatin, ZO-1 and occludin were in close proximity, regardless of ZO-2 depletion (arrows, Figure S3D ). However, in the presence of blebbistatin, ZO-1 was not associated with occludin when ZO-2 was depleted (arrowhead, Figure S3E ).
In summary, loss of either actin filament organization or myosin activity in cells lacking one ZO protein, e.g., conditions that lead to the folded and/or disordered conformation of ZO-1 (Figure 1 ), results in decreased junctional localization of DbpA and occludin, suggesting loss of interaction with the other ZO protein. These results also suggest that, similarly to ZO-1, ZO-2 undergoes tension-dependent stretching, and that stretching activates both ZO proteins by promoting their interaction with DbpA and occludin.
Tension Controls Gene Expression, Cell Proliferation, and Paracellular Barrier Function through ZO Proteins To probe the cellular consequences of force-dependent conformational changes of ZO proteins, we analyzed signaling outputs by DbpA [23, 28] and occludin [29] [30] [31] .
In ZO-1-KO cells treated with blebbistatin and MG132, which display nuclear DbpA labeling ( Figure 3F ), cell proliferation was increased, as determined by Ki67 labeling, and this increase was reduced upon depletion of DbpA, indicating that it was DbpA dependent ( Figures 4A-4B' ). When DbpA was nuclear, qRT-PCR showed increased expression of the DbpA target genes cyclin D1 (CCD1) and PCNA ( Figure 4C ) and decreased expression of ErbB2 ( Figure 4D ). These changes did not occur in ZO-1-KO cells treated with blebbistatin alone (Figures 4C and  4D ), when DbpA is not nuclear, and its levels are reduced ( Figures  3F-3H ). The changes in DbpA localization cannot be due to the effect of treatments on other proteins, because only ZO-1 and ZO-2 regulate DbpA junctional localization in confluent cells [24] .
Regarding barrier function, in the absence of blebbistatin, no significant differences were observed in permeability either to ions (transepithelial electrical resistance [TEER]; Figure 4E ) or larger molecules (P app ; Figure 4F ) when comparing monolayers of WT and ZO-1-KO cells, in agreement with previous results [21] . However, blebbistatin induced an increase in the TEER of WT cells, and this increase was not as strong in ZO-1-KO cells (TEER; Figure 4E ). In addition, blebbistatin treatment resulted in a higher flux of fluorescein isothiocyanate (FITC)-dextran in ZO-1-KO, but not WT cells ( Figure 4F ), suggesting that the barrier is more sensitive to loss of actomyosin tension when only ZO-2 is expressed.
Together, these results suggest that the organization and contractility of the actomyosin cytoskeleton controls both DbpA-dependent regulation of gene expression and occludindependent regulation of barrier function in a ZO-dependent manner.
Substrate Stiffness and Actomyosin Contractility Modulate Epithelial Proliferation and Cyst Morphogenesis through ZO Proteins
Because substrate stiffness influences intracellular tension, we examined cyst morphogenesis in 3D cultures of Eph4 cells grown in Matrigel, a soft, more physiological substrate than glass coverslips [36] . WT Eph4 cells formed cysts with a lumen, and their size increased to $250 mm within 21 days (Figures 5A and 5E), correlating with normal cell numbers and proliferation ( Figures S4A, S4E , and S4F). In contrast, ZO-1-KO cysts grew slowly and had a diameter of $50 mm and no lumen after 21 days ( Figures 5C and 5E ) and decreased cell numbers and proliferation ( Figures S4C, S4E , and S4F). To ask whether this was due to low contractility, we treated cells with 2 0 -deoxyadenosine-5-triphosphate (dATP) ( Figures 5B and 5D) [37], which enhanced actin filament formation and myosin light chain phosphorylation ( Figures S4B, S4D , and S4G-S4I). dATP did not affect the growth rate and size of WT cysts ( Figures 5B and 5E ), but it rescued the stunted growth phenotype of ZO-1-KO cysts, resulting in size, cell number, and proliferation similar to WT (Figures 5D , 5E, S4E, and S4F). DbpA levels were reduced in ZO-1-KO cysts, compared to WT, and were rescued by dATP (Figure 5F ). In WT cysts, DbpA was nuclear at early time points, whereas later, it was sequestered at junctions (Figures 5G and 5H), both with and without dATP. In contrast, DbpA was low or undetectable in ZO-1-KO cysts both at early and late time points ( Figures 5I and 5J ). dATP rescued both the expression ( Figure 5F ) and localization ( Figures 5I and 5J ) of DbpA, correlating with increased cyst growth ( Figures S4A-S4F ), and its activity was antagonized by blebbistatin ( Figure S4J ). E-cadherin was localized at junctions in both WT and ZO-1-KO cells, independently of dATP ( Figures 5G-5J ), in agreement with [21] . In summary, growth in Matrigel produced similar effects on DbpA Figure S7 shows schematically the different fates of DbpA and its activity on target genes, depending on the experimental conditions. expression, localization, and signaling as blebbistatin treatment of 2D cultures on coverslips, and on a soft substrate, expression of ZO-2 alone was not sufficient to sequester DbpA at junctions, unless contractility was stimulated by dATP.
Intra-molecular Interactions within ZO Proteins Prevent Their Binding to DbpA and Occludin and Are Inhibited by Heterodimerization and by Force
We hypothesized that the conformation of ZO proteins corresponding to overlapped localization of N and C termini of ZO-1 ( Figure 1 ) involves an auto-inhibitory intra-molecular interaction between C-terminal and N-terminal regions, which prevents DbpA and occludin binding to the ZPSG domains. To test this, we used glutathione S-transferase (GST) pull-down experiments, and first showed that DbpA interacts with ZPSG-1 and ZPSG-2, but not with ZPSG-3, whereas all ZPSGs interact with GST-occludin ( Figure S5 ). Next, we examined the potential interactions between the ZPSG and C-terminal regions of ZO-1 and ZO-2 ( Figures 6A-6D ). Different constructs of the C-terminal region of ZO-1 interacted with ZPSG-1, the strongest signal given by the extreme C-terminal fragment of ZO-1 (1,619-1,748 = Cter; Figures 6A-6B'). Similarly, the C-terminal region of ZO-2 interacted with ZPSG-2 ( Figures 6C and 6D ). Thus, both ZO-1 and ZO-2 can potentially undergo intra-molecular interactions between their respective ZPSG and C-terminal regions.
Next, we asked whether the interaction of the C-terminal region of ZO-1 with ZPSG-1 inhibits ZPSG-1 binding to either DbpA or occludin. The Cter and DbpA interact with the same domain (SH3) within ZPSG-1 ( Figures S6A-S6C ), suggesting the possibility of a competition. Competition GST pull-down assays were conducted using HA-tagged DbpA as a prey, without or with increasing amounts of competing C-terminal fragments of ZO-1 ( Figures 6E-6G ). The interaction between DbpA and ZPSG-1 was not inhibited by GFP, but was inhibited by GFPtagged fragments of the C-terminal region of ZO-1, the most C-terminal fragment (residues 1,619-1,748 = Cter) being the most effective ( Figures 6E-6G) . Similarly, DbpA, but not CFP, inhibited the interaction between the ZPSG and the C-terminal region of ZO-2 ( Figures S6D-S6F ). The dissociation equilibrium constants (K d s) [38] for the interaction of ZPSG-1 with Cter and with DbpA were 66 nM and 100 nM, respectively (Figures S6G-S6J), suggesting that binding of Cter to the ZPSG can result in DbpA dissociation. Finally, competition pull-down assays using the C-terminal region of occludin as a prey showed that the GFP-tagged Cter, but not GFP alone, inhibited the interaction between ZPSG-1 and the C-terminal region of occludin ( Figures 6H-6J ). Together, these data indicate that the C-terminal regions of ZO proteins can compete with the ZPSG interactors DbpA and occludin for binding to the ZPSG. Because full-length ZO-1 does not interact with GST-DbpA [24] , and experiments on cells indicated a role of heterodimerization in stabilizing the stretched conformation of ZO-1 under low tension (Figure 3) , we asked whether ZO-2 promotes the interaction of ZO-1 with DbpA. Using GST-DbpA as a bait, we detected ZO-1 in pull-downs when increasing amounts of vsvtagged ZO-2 ( Figures 6K-6M ), but not p114-RhoGEF ( Figures  6L and 6M ) was present. This suggests that heterodimerization stabilizes the stretched ZO-1 conformation in vitro, thus promoting ZPSG-ligand interactions.
Finally, we investigated whether the postulated auto-inhibitory interaction between the ZPSG and Cter of ZO-1 is regulated by force. We designed a construct where these domains are separated by a long flexible (FH1) linker and spanned between mechanically stable titin (I27) domains ( Figure 7A ). The Cter was allowed to interact with the ZPSG by keeping a near-zero force (<1 pN) for several minutes. Then, force was increased (loading rate 1 pN/s) to induce rupture of the ZPSG-Cter complex, resulting in a large extension increase step, due to releasing of the FH1 loop, in addition to the unfolding of the ZPSG domains (PDZ3, SH3, and GUK; Figure 7B ). Next, force was decreased (À1 pN/s) to allow refolding of the domains and reformation of the complex before the next force-increase scan. Representative force-extension curves from the same molecule show typically three extension-jump events in each force-increase scan ( Figure 7B ). The events with step sizes of $20-50 nm ($60-200 residues) most likely correspond to the unfolding of the ZPSG domains. In addition, the step with the largest size (>100 nm) at forces of 5-20 pN (release of >300 aa) is consistent with the rupture of the ZPSG-Cter interaction, which releases the FH1 loop (182 aa) and the Cter (129 aa). To quantify the force-dependent unfolding of the domains and the rupture of the ZPSG-Cter interaction, the distributions of the unfolding contour lengths and the corresponding number of released residues involved were plotted ( Figure 7C ). Interestingly, the rupture forces of the ZPSG-Cter interaction (events involving R300 released residues) distribute widely from 5 to 40 pN at 1 pN/s loading rate ( Figure 7D ). One possibility is that the ZPSG-Cter interaction takes place under different orientations ( Figure 7A ), resulting in a shear force or an unzipping force stretching geometry, which have different force-dependent rupture kinetics. The majority of domain-unfolding events (involving <300 aa) are distributed at forces of $5-15 pN ( Figure 7D ), consistent with the data obtained from the unfolding force distribution of the ZPSG domain alone ( Figures 7E and 7F ) and also consistent with the unfolding force distribution of fulllength ZO-1 (Figure 2) . The small fraction of unfolding events at >20 pN ( Figure 7F ) might indicate that the domains (SH3/GUK) could be within the loop stabilized by the ZPSG-Cter interaction, which is excluded from the force-transmission pathway until rupture of the complex.
DISCUSSION
ZO-1 and ZO-2 are essential to assemble epithelial barriers and to organize the junctional actomyosin cytoskeleton through their interaction with TJ membrane proteins, actin-binding proteins, and regulators of Rho guanosine triphosphatases (GTPases) (reviewed in [13] ). Thus, understanding how actomyosin contractility controls the conformation and functions of ZO-1 and ZO-2 is essential to clarify the mechanistic interplay between the cytoskeleton and TJ, and its effects on cell behavior. The ZPSG is critical for the junctional localization of ZO-1 and its interaction with occludin, as well as for barrier formation and epithelial polarization [14, 16, [39] [40] [41] [42] . Our experiments extend previous studies by showing that the C-terminal regions of ZO-1 and ZO-2 interact with their respective ZPSGs and that the Cter of ZO-1 inhibits the binding of DbpA and occludin to the ZPSG-1. Force is required to disrupt the Cter-ZPSG-1 interaction in vitro, and we speculate that, within cells, force may act both by disrupting the Cter-ZPSG-1 interaction and by affecting intra-molecular interactions within the ZPSG-1 [16] to allow modulation of ligand binding ( Figure S7 ). Because the C-terminal half of ZO-1 most likely has a disordered conformation and is mechanically weak, the full-length protein can be extended at forces (2-4 pN), within the physiological range [43] . Collectively, our experiments suggest that force acts as an allosteric effector, by stretching ZO proteins, to promote the interaction of the ZPSG with its ligands. PDZ2-mediated heterodimerization, which is important for the circumferential distribution of ZO-1 at TJ [41] and for the claudin scaffolding functions of ZO proteins [39] , also promotes the stretched conformation of ZO-1. We propose that the stretched conformation of ZO proteins is the active conformation, whereas the folded and/or disordered conformation is the inactive form, where the ZPSG region is auto-inhibited ( Figure S7 ). Because the ZPSG-1 also binds to a-catenin, afadin, JAM, Apg-2, vinculin, and Shroom2 [13] , force-dependent changes in ZO-1 conformation may also regulate its interaction with these proteins.
We used SIM and PLA to characterize the conformations of ZO-1. In the stretched conformation, the N-terminal and C-terminal ends of ZO-1 were separated by z75 nm, which is compatible with the number of residues of ZO-1, although this is probably not an accurate measure of molecular length, due to tags, fixation, and potential bends in the molecule. The spatial separation between the ends of ZO-1 is in agreement with biotin-ligase tagging experiments, showing that the N and C termini of ZO-1 are embedded in different functional subcompartments of the TJ [44] , and with immunoelectron microscopy and SIM experiments, showing that cingulin, which is enriched in the ZO-1 C-terminal compartment [44] , is farther away from the TJ membrane than ZO-1 [45, 46] . Because the N-terminal half of ZO-1 binds to junctional membrane components, whereas the C-terminal half associates with cytoplasmic actin filaments [11, 12, 14] , in the stretched conformation the N-terminal region should be immediately proximal to the membrane, whereas the C-terminal region should extend at some angle toward the cell interior, interacting with actin filaments ( Figures  S7A-S7C ). It is difficult to define precisely the spatial configuration of ZO-1 when its N and C termini are overlapped by SIM and generate a junctional PLA signal. Our interpretation that an intramolecular self-looping interaction occurs between the C-terminal and ZPSG domains of ZO-1, leading to auto-inhibitory folding ( Figure S7D) , is based on (1) the interaction of ZPSG-1 with C-terminal fragments of ZO-1, suggesting that this interaction could occur in vivo; (2) magnetic tweezers experiments, showing that force is required to dissociate the Cter of ZO-1 from the ZPSG-1, suggesting that in cells, actomyosin contractility could disrupt the same interaction within the full-length molecule; and (3) competition experiments showing that the Cter competes with DbpA and occludin for binding to the ZPSG in vitro, accounting for the reduced junctional accumulation of DbpA and occludin in intact cells. An alternative hypothesis is that the colocalization of the ends of ZO-1 may be due to inter-molecular interactions between stretched molecules following their disordered collapse induced by loss of tension. This hypothesis would require, in contrast to evidence [11, 12, 14] , either that ZO-1 undergoes head-to-tail aggregation, and/or that the C-terminal region of ZO-1 binds with high affinity, independently of the N-terminal region, to heterologous junctional components, in order to be retained proximal to the junctional membrane. Furthermore, if ZO-1 was stretched, the DbpA and occludin binding sites should be available, at variance with the decrease in their junctional localization under low tension, and there should be a wider distribution of the overlapped signal, because molecules would be distributed at random angles. The possibility that inter-molecular interactions occur in cis is also unlikely, because although ZO-1 molecules along TJ membrane may be closely spaced [47] , the intra-molecular interaction is always more favorable, based on Boltzmann distribution. In summary, it is more likely that, in the absence of tension, junctional ZO-1 remains anchored to the membrane through binding of N-terminal domains to their interactors, whereas the C-terminal half of the molecule binds intra-molecularly to the ZPSG ( Figure S7D ). Additional mutagenesis, structural, and fluorescence resonance energy transfer (FRET) studies will be required to clarify the organization of ZO-1 in its folded and/or disordered conformation, with the caveat that mutations and FRET sensors could alter ZO-1 functional behavior and intra-molecular interactions within the ZPSG [16] . Here, we added tags to the ends of ZO-1 to minimize artifacts due to insertions/mutations within conformation-sensitive regions. We also propose that ZO-2 has forcedependent stretched/folded conformations, but additional studies will be required to confirm this hypothesis.
A limitation of our approach is that we analyzed fixed cells, where soluble proteins may be removed by permeabilization. Fluorescence recovery after photobleaching (FRAP) studies show that in vivo the association of ZO-1 with the membrane is dynamic, with a cytosolic pool in equilibrium with a membrane-associated pool [48] . We speculate that the folded conformation is enriched in the cytosolic pool and prior to junction assembly, whereas heterodimerization and association with actomyosin enhances the junctional assembly of ZO proteins, by locking them in a stretched conformation, which promotes binding to ZPSG ligands. This model is in agreement with previous experiments showing that ZO-1 lacking the whole C terminus localizes only partially to junctions [14] and that ZO-1 mutants lacking the actin-binding domain display a significantly greater mobile fraction [8] , indicating that linkage to actomyosin greatly enhances the junctional localization of ZO-1. To explore further the role of heterodimerization and of interactions between the Cter and ZPSG domains on the dynamics of ZO-1 exchange in vivo will require detailed mutagenesis, structural, and FRET analyses, with the above-mentioned caveats.
We investigated the cellular consequences of tension-dependent ZO protein functions by focusing on how the localization and expression of occludin and DbpA correlated with changes in barrier function, cell proliferation, and cyst growth. Loss of ZO-1 combined with blebbistatin treatment resulted in decreased barrier function, in agreement with [7, 8] . The decreased junctional localization of occludin under these conditions may be mechanistically relevant, although the precise role of occludin in the regulation of paracellular permeability is unclear [29] [30] [31] [32] . Stretching of ZO proteins could therefore represent a mechanism to couple force generation by the actin cytoskeleton to the strengthening of the TJ barrier. With regards to DbpA, its loss from junctions and degradation correlated with decreased cell proliferation, in agreement with previous studies [28] . The effects of MG132 and dATP suggest that tension-and ZOdependent sequestration of DbpA in interphase cells is required for stabilization and subsequent DbpA activation in proliferating cells. Interestingly, whereas we observed a slow growth and proliferation of ZO-1-KO Eph4 cysts, depletion of ZO-1 in MDCK cells does not decrease cyst size and proliferation [28, 42] . DbpA localization and expression were not determined in previous studies [28, 42] , so these discrepancies may be due to different cellular models (Eph4 versus MDCK cells) and experimental approaches (KO/KD, collagen/Matrigel). Collectively, our observations suggest that junctional mechanics modulate the stability and signaling of DbpA through ZO proteins, affecting epithelial proliferation and morphogenesis.
In summary, we provide evidence that ZO-1 exists in different force-dependent conformations and that myosin-II-dependent contractility and actin organization, as well as heterodimerization, regulate the functional interactions of ZO-1 and ZO-2. We propose that activation of ZO proteins by stretching is a new mechanism of cross-talk between the contractile cytoskeleton and junctions, whereby force orchestrates junctional organization, barrier function, and nuclear signaling by regulating the ZPSG-dependent recruitment of ZO protein ligands. This could be a novel mechanism through which forces regulate homeostasis of epithelia and endothelia.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Eph4 WT (a kind gift of E. Reichmann, University of Zurich) and Eph4 ZO-1-KO cells (a kind gift of S. Tsukita, Osaka University) were cultured at 37 C, 5% CO 2 , in Dulbecco's modified Eagle's medium (DMEM, GIBCO) containing 10% fetal bovine serum (FBS), 1% non-essential amino acids (Invitrogen). Eph4 cells come from female mice (http://web.expasy.org/cellosaurus/CVCL_0073), and we trusted our providers regarding their authentication. For 2D culture and transfections cells were cultured on glass coverslips (12 mm diameter, cat. N.92101401060, Karl Hecht, Sondheim, Germany). For 3D cultures, 40 mL Matrigel (BD Biosciences No. 354230; final concentration 10 mg/mL) was added to each glass coverslip in a 24-well plate, and allowed to solidify for 15 min at 37 C. Next, cells were trypsinized, triturated in 2 mL of SMEM medium (Spinner Modification, with Earle's salts and sodium bicarbonate, without calcium chloride and L-glutamine, Sigma-Aldrich, M8167) to obtain a single-cell suspension, counted, diluted, and plated at 5000 cells/ well in ''Assay Medium'' (AM = DMEM supplemented with 2% Matrigel, 5 mg/mL insulin, Sigma-Aldrich, 91077C, 1 mg/mL hydrocortisone, Sigma-Aldrich, 50-23-7, and 3 mg/mL prolactin, Sigma-Aldrich, SRP4689) on Matrigel-coated coverslips. Cysts were grown for up to 21 days at 37 C, 5% CO 2 , replacing with fresh medium every 3 days.
METHOD DETAILS
Antibodies and immunofluorescence Antibodies are described in Key Resources Table. Immunofluorescence of cells on coverslips and immunoblotting were carried out as described previously [24] . For immunofluorescence of cysts grown in Matrigel, fixation was with PFA 3% for 20 min at room temperature (RT) followed by permeabilization with PBS containing 0.5% Triton X-100 (10 min at 4 C), except for DbpA detection, where the cells were permeabilized with actin stabilization buffer (100 mM KCl, 3 mM MgCl 2 , 1 mM CaCl 2 , 200 mM sucrose, 10 mM HEPES, pH 7.1) containing 0.1% Triton X-100 (5 min at RT) and then fixed using a 1:1 mixture of methanol:acetone at 20 C for 10-12 min. Next, samples were blocked by incubating the coverslips in 200 ml/well IF Buffer (PBS/glycine+7.7 mM NaN 3 , 0.5% bovine serum albumin, 0.2% Triton X-100, 0.05% Tween-20) for 2 hr at RT. Primary antibodies were diluted in IF buffer and incubated for 16 hr at RT under gentle agitation, followed by three washes in IF buffer (each 20 min at RT). Secondary antibodies were diluted in IF Buffer and incubated for 4 hr at RT. For PLA and SIM immunofluorescence experiments, cells were seeded in 12-well plates at a density of 100,000 cells/well.
Plasmids GST-ZPSG-1, GST-DbpA, HA-DbpA, HA-CFP were described in [24] . Note that The ZPSG-1 construct lacks the U6 domain, which inhibits binding of occludin [16] . The GST-tagged C-terminal domain of ZO-2 (residues 890-1190) was obtained by PCR and subcloning into XhoI-XmaI and EcoRI-NotI sites of pGEX4T1. GST-tagged C-terminal domain of occludin (residues 371-521) was a kind gift from Jim Anderson (NIH, Bethesda). GST-tagged deletion mutants of the ZPSG region (ZS1: 509-597; ZP1: 409-509; ZPS-1: 409-597; ZSG-1: 509-779; ZG-1: 598-779) were obtained by PCR using Q5 High fidelity Polymerase (NEB, M0491L) and subcloning into BamH1-NotI sites of pGEX-4T1. GFP-tagged constructs of fragments within the C-terminal region of human ZO-1 (residues 888-1619; 1150-1619; 888-1748; 1150-1748; 1619-1748), and of ZPSG domains of ZO-1 (residues 417-806) and ZO-2 (residues 509-880) were obtained by PCR and subcloned downstream of GFP into NotI-KpnI sites of pCDNA3.1(+). The ZPSG domain of ZO-3 (residues 369-750) was obtained by PCR and subcloned downstream of GFP into BamHI-XbaI sites of pCDNA 3.1 (+). The HA tagged C-terminal region of occludin (residues 406-521) was obtained by PCR and subcloned into KpnI-NotI sites of pCDNA3.1(+). The avi-FL-hZO-1-spy construct for magnetic tweezers experiments was generated by PCR of an insect-optimized synthetic ZO-1 gene (Genscript) followed by cloning into the BamHI and SalI sites of vector pACEBac1 (a kind gift of Thomas Schalch, University of Geneva) by Gibson assembly. The human myc-ZO-1-HA construct was obtained by PCR using a 5 0 oligonucleotide containing the myc sequence, and subcloned (BamHI and XhoI) upstream of the HA tag in a modified version of the pcDNA3.1 mammalian expression vector. The construct codes for a protein of 1777 aminoacids (including 1748 amino acids of ZO-1 sequence), with a theoretical maximal length of >600 nm. His-tagged DbpA was obtained by PCR and subcloned into BamHI-BglII of pRSET. His-tagged SNT-1 (Suc-1 associated neurotrophic factor target protein) cloned into XbaI-BamHI of pET-21b was a gift from D. Shore (University of Geneva), as was used as negative control (unrelated His-tagged protein). The ZPSG-1 (residues 417-806, human ZO-1) plasmid for in vitro magnetic tweezers experiment was prepared as follows: (1), the ZPSG DNA fragment (with HindIII-XhoI sites at two ends) was amplified from the FL-ZO-1 plasmid sequence by PCR using Q5 High fidelity Polymerase; (2), a pET151 vector is specially designed with avi-tag, four repeats of human titin 27th Immunoglobulin domain (aka, I27; 93 residues; PDB: 1WAA_A), and followed with a spy-tag (the designed vector was synthesized by geneArt). There is a pair of HindIII-XhoI sites between the second and the third I27 domain; (3), the ZPSG DNA fragment was then inserted into the vector by double-digestion ligation, resulting in a pET151-avi-I27-I27-ZPSG-I27-I27-spy plasmid construct. Similarly, the ZPSG-FH1-Cter plasmid for in vitro experiment was prepared as follows: (1), the ZPSG DNA (HindIII-EcoRI sites at two ends) and Cter DNA (BamHI-XhoI sites at two ends) fragments were amplified from the FL-ZO-1 plasmid sequence by PCR; (2), the FH1 DNA (with EcoRI-BamHI sites at two ends) fragment (corresponding to human formin mDia1, residues 583-764) was synthesized by geneArt; (3), the ZPSG, FH1 and Cter DNA fragments were assembled into the above mentioned pET151 vector by double-digestion ligation, resulting in a pET151-avi-I27-I27-ZPSG-FH1-Cter-I27-I27-spy plasmid construct. Between each domain, there are flexible linkers (GGGSG) to ensure the unfolding/refolding of each domain is independent.
qRT-PCR Quantitative RT-PCR was carried out as described previously [1] , using the following primers: HPRT (internal standard), forward 5 0 -tggacaggactgagcggc-3 0 and reverse 5 0 -tgagcacacagagggctacg-3 0 ; Cyclin D1, forward 5 0 -aagtgcgtgcagaaggagat-3 and reverse 5 0 -cacaacttctcggcagtcaa-3 0 , PCNA, forward 5 0 -gcacgtatatgccgagacct-3 and reverse 5 0 -cagtggagtggcttttgtga-3 0 , ErbB2, forward 5 0 -gagccttcggcactgtctgtctac-3 0 and reverse 5 0 -agctgcactgtggatgtcag-3 0 .
Recombinant Protein Expression, Glutathione S-Transferase (GST) Pulldown, and Supernatant Depletion Assays GST fusion proteins were expressed in BL21(DE3) bacteria and purified by affinity chromatography on Glutathione-Sepharose beads [24] . Cell lysates for pull-down experiments were obtained by washing cells twice in ice-cold PBS and lysis in coimmunoprecipitation (CO-IP) buffer (150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 1% Nonidet P-40, 1 mM EDTA, and complete protease inhibitor) for 15 min at 4 C. Lysates were centrifuged for 15 min at 13,000 rpm and incubated at 4 C with Sepharose beads previously conjugated with recombinant proteins. Pulldowns using lysates from insect cells expressing full-length ZO-1, or HEK293T cells expressing vsv-tagged-ZO-2 or vsv-tagged-ZO-1 and GST-DbpA were carried out as described [24] . Competition binding experiments for ZO-1 were carried out by incubating GST-ZSPG1 (5 mg) with HEK293T lysate containing HA-DbpA, in the presence of increasing amounts (0, 2, 5, 10, 20, 50, 75 ml) of normalized HEK293T cells lysates containing either GFP or GFP-tagged C-terminal ZO-1 fragments. Competition pulldown experiments for ZO-2 were carried out by incubating GST-tagged C-terminal domain of ZO-2 (residues 890-1190) with HEK293T lysate containing GFP-ZPSG-2, in the presence of increasing amounts of lysate containing either HA-CFP or HA-DbpA. To determine the K d of interaction between the ZPSG fragment and either the C-terminal region of ZO-1, or DbpA, we used a quantitative GST-pulldown Supernatant Depletion Assay [38] . Increasing volumes (1, 2, 5, 10, 12.5, 15, 17.5, and 20 ml) of Gutathione Sepharose beads pre-loaded with GST-ZPSG-1 bait (0.666 mM), were added to prey protein (either HA-DbpA or GFP-ZO-1-C-terminal), in a total volume of 0.5 mL CO-IP buffer. As a negative control, beads pre-incubated with CO-IP buffer (1, 2, 5, 10 ml) were added to the prey. After 16 hr incubation at 4 C, beads were pelleted at 16,000 x g, and the prey proteins remaining in the supernatant were analyzed by SDS-PAGE and immunoblotting. GST pulldown experiments to assess the effect of heterodimerization on the interaction between DbpA and full-length ZO-1 were carried out by incubating GST-DbpA (5 mg) with insect cell lysate containing full-length ZO-1, in the presence of increasing volumes of normalized HEK293T cells lysates containing either vsv-ZO-2 (a kind gift from A. Fanning, University of North Carolina), or vsv-p114-Rho-GEF (a kind gift from MS Balda and K. Matter, University College London), this latter as a negative control. Although it is unlikely that sufficient concentrations of additional interacting partners of baits and preys are present in the GST pulldown assays and might influence some of the results, this possibility cannot be formally excluded. Concentration of recombinant proteins was determined by densitometric analysis of Coomassie-stained SDS gels, compared to a BSA standard curve.
Purification of recombinant proteins for magnetic tweezer experiments
Baculovirus generated using the full-length human avi-ZO-1-spy construct in pACEBac1 was used to transduce insect cell (Sf9) cultures (50 mL virus per 1 l cell culture, at 1x10 6 cells/mL). After 3 days of culture (under gentle rotation, at 27 C) cells were harvested by centrifugation at (1000 rpm, 10 min at 4 C), and the cell pellet was resuspended in 20 mL of PBS, containing protease inhibitors. Drops of cell suspension were frozen in liquid nitrogen, to obtain insect cell ''beads.'' For purification, beads were resuspended in CO-IP buffer (1:3 w:w) at 4 C until, complete thawing. The lysate was centrifuged (10,000 rpm for 20 min at 4 C) and the supernatant was incubated with 2 mL Streptactin resin (Lucerna Chem AG cat. n. 2-1208-010) previously washed with CO-IP buffer, in a 20 mL column (Biorad cat n. 732.1010) under gentle agitation at 4 C for 4 hr. The flow through was collected, and the resin was washed with CO-IP buffer (10x, 5 mL each time). The protein was eluted with 6 mL elution buffer (CO-IP buffer containing 5 mM desthiobiotin, Sigma cat. n. D1411-1G). The Strep-tag used for purification was removed by digesting the purified protein with TEV protease (5 mL of 1 mg/mL stock) overnight at 4 C. The sample was dialysed against biotinylation buffer (50 mM bicin, 10 mM MgOAc, 4 C for 4 hr), and concentrated using Amicon Ultra centrifugal filter units (cat n. UFC801024). The concentrated protein was biotinylated (Avidity kit, cat. n. BirA500) for 1 hr at RT. The biotinylated protein was finally purified by gel filtration on a Sephadex S200 column equilibrated in CO-IP buffer. Fractions containing biotinylated ZO-1 were collected, concentrated, analyzed by IB using anti-avi antibody, lyophylized and stored at À80
. For the purification of avi-2I27-ZPSG-2I27-spy and avi-2I27-ZPSG-FH1-Cter-2I27-spy, the pET151-avi-ZPSG-spy plasmid or the pET151-avi-ZPSG-FH1-Cter-spy plasmid were co-transformed with a BirA plasmid and expressed in Escherichia coli BL21 (DE3) cultured in Luria-Bertani (LB) media using IPTG induction with biotin in media, and then affinity purified through his-tag purification. The BirA was used for in vivo biotinylation of the N-teminus avi-tag.
Single-protein stretching using magnetic tweezers A vertical magnetic tweezers setup [34, 35] was used for in vitro stretching of single full-length ZO-1 and its sub-domains. In a flow channel, the C terminus end of individual proteins (full-length ZO-1, ZPSG, or ZPSG-FH1-Cter) was attached to a spycatcher coated bottom coverslip, through the specific interaction of spy-spycatcher. The N terminus of the full-length ZO-1 was attached to a streptavidin-coated paramagnetic bead (2.8-mm in diameter, Dynabeads M-270 Streptavidin, Invitrogen) through the specific interaction of biotin-streptavidin. To probe the force-dependent interaction between ZPSG and Cter domains the two domains were separated by FH1 (non-structured formin homology domain from mDia, 182 aa), and spanned between two titin I27 domains, that serve as handles and which unfold at >80 pN at our loading rate.The N terminus of the ZPSG or ZPSG-FH1-Cter was linked to a streptavidin, which was then linked to a biotin-DNA (576-bp) coated paramagnetic bead (2.8-mm in diameter, Dynabeads M-270 Epoxy, Invitrogen). The inserts (ZPSG or ZPSG-FH1-Cter) were flanked on each side by two titin I27 domains, which act as handles. The biotin-DNA (576-bp), acting as a handle to further increase th distance between the bead and surface for short protein tethers. The DNA handle (576-bp) was PCRed from lambda-phage DNA, with biotin and thiol labeled on each primers. The thiol was used to link the DNA to Epoxy bead. The force was applied by a pair of motorized magnets. The extension of the protein (the N-to-C distance along the force direction) was recorded at difference forces. The experiments were performed in buffered solutions containing 1X PBS (pH7.4), 1% BSA, 1 mM EGTA, 0.05% Tween20, 5 mM DTT at 22 ± 1 C. Additional details of the protocol of magnetic tweezers setup and experiments can be found in [34] . Each extension jump of the colored curves in Figure 2 indicates an unfolding of a domain or sub-domain during force-increase scans (with a loading rate of 1 pN/s). The force-decrease scans were performed with a loading rate of À5 pN/s to $10 pN (reduce the duration at high forces to avoid tether break), and then followed by À0.1 pN/s to $1 pN. Magenta lines in Figure 2C are 10-points FFT smooth of the raw data (light gray), the black line shows the extension of folded ZO-1 at corresponding forces, the dashed box indicates the region where refolding events occur.
Relation between domain unfolding/refolding step size, contour length and the number of residues involved The force-extension curve of a folded domain (i.e., PDZ, GUK, SH3, ZU5, etc.) is determined by the rigid rotation fluctuation of a characteristic rigid-body with a length b $2-5 nm, which is the distance between the two force-attaching points (i.e., the N-to C-terminal distance) in the folded state. This force-extension curve of the folded domain can be described by the freely-jointed chain polymer model with a single segment:
The unfolded state of the domain is a flexible peptide chain, and this force-extension curve can be described by the worm-like chain (WLC) polymer model with a bending persistence length of A $0.8 nm. The force-extension curve of unfolded domain can be evaluated as the inverse function of the Marko-Siggia formula:
where L wlc = N s 3 0.38 nm is the contour length of the chain, with N_s is the number of the residues in the structured domain. Therefore, the force-dependent step-size of a domain is
In experiments, the step sizes of the unfolding/refolding of a domain and the corresponding forces were recorded, i.e., Dx(f) is experimentally obtained. Hence, based on the Equation 1, the contour length L wlc and the number of residues N s involved in a domain can be estimated. For instance, an unfolding step of $20-25 nm at a force of $15 pN corresponds to unfolding of a domain involving $100 residues. There are six known structured domains in ZO-1: PDZ1-3: 88 aa, 79 aa, and 82 aa, SH3: 69 aa, GUK: 182 aa, and U5: 115 aa. The force-dependent unfolding step sizes of these domains are plotted in Figure S2 . In these calculations, the folded domain size b is set as 2 nm. We note that the characteristic rigid-body length b in the range of 2-5 nm does not affect the estimation of contour length and residues number significantly.
Estimation of forces on ZO-1 in vivo based on the stretched conformation of ZO-1 The distance between the two termini (N-to-C) of the stretched ZO-1 in vivo is estimated to be $75-100 nm by SIM (Figure 1) . Based on the magnetic tweezers experiments on stretching of full-length ZO-1, $600-900 residues are structured and can withstand forces R 5 pN (Figure 2) , while the remaining $900-1100 residues might be mechanically week or non-structured. We calculated the force level in FL-ZO-1 assuming that all the structured domains are folded and the rest is in a peptide conformation. Its forceextension curve, Considering that the actin filament might bind to different sites within the C-terminal ABR of ZO-1, the non-structured residues under force may vary. Therefore, we calculated the force response of FL-ZO-1 with the number of non-structured residues in a wide range of 600-1100 aa, i.e., $35%-65% of the FL-ZO-1 ( Figure 2F ). The result shows over an N-to-C extension range of $75-100 nm, the force in ZO-1 is in the range of 2-4 pN. In this force range, the structured domains remain folded. Therefore, based on our assumption of a 50%-65% fraction of FL-ZO-1 in a non-structured peptide conformation, we reason that in living cells, the force in FL-ZO-1 might be in a range of 2-4 pN, and at which forces, most of its structural domains remain folded.
siRNA-mediated ZO-2 depletion and exogenous expression of myc-ZO-1-HA For siRNA-mediated ZO-2 depletion cells were transfected with Lipofectamine RNAiMAX (Invitrogen) 24 hr after plating, according to the manufacturer's instructions. siRNA negative control was obtained from Sigma (cat. N. SIC001). siRNA for mouse ZO-2 was: forward, 5
0 -ctcctatcacgaagcttat and reverse, 5 0 -ataagcttcgtgataggag. For transient overexpression (for PLA and SIM experiments) of myc-ZO-1-HA, cells were transfected with a mix of DNA and Lipofectamine 2000 (Invitrogen) 24 hr after plating, according to the manufacturer's instructions, and grown under zeocin selection (250 mg/mL, R25001, Invitrogen) for 48 hr to 72 hr after transfection.
Treatment with drugs
The following drugs were used: latrunculinA (LAT-A), which prevents the polymerization of actin filaments (stock 200 mM in DMSO, 200 nM final concentration, L5163 Sigma-Aldrich), CK-879, which inhibits nucleation of branched actin filaments (50 mM stock in DMSO, 150 mM final concentration, C9124 Sigma-Aldrich). SMIFH2, which inhibits nucleation of bundled actin filaments (50 mM in DMSO, 50 mM final dilution, S4826, Sigma-Aldrich), blebbistatin (BL), which inhibits the ATPase activity of myosin (50 mM in DMSO, 50 mM final concentration, B0560, Sigma-Aldrich), proteasome inhibitor MG132 (MG)(250 mM in DMSO, 50 mM final concentration, C-2211 Sigma-Aldrich), dATP, which enhances actomyosin contractility (R0141, Thermo Scientific 1 mM final concentration). The final concentrations were determined on the basis of dose-response curves (not shown), where drugs were not effective at the lowest concentration. Solvent alone (DMSO) was used for control experiments. Treatment with drugs was for 2-4 hr (actin drugs) and 4-12 hr (blebbistatin) at 37 C prior to immunofluorescence or cell lysis.
Immunoblotting
Cell lysates were obtained using RIPA buffer containing 1X Roche anti-protease inhibitor [1] . In the case of transfected cells, lysates were obtained 48-72 hr after transfection. For immunoblotting analysis of cells from cysts grown in Matrigel, samples were rinsed with trypsin (1 mL, 0.25%), trypsinized using 0.5 mL/well of trypsin solution, thoroughly resuspended by pipetting, and incubated for 30 min at 37 C. After centrifugation at 13.000 rpm (3 min at 4 C) cells were washed once with Assay Medium, to quench trypsin, and once with PBS. Pellets were resuspended in RIPA buffer (50 ml) supplemented with protease inhibitors, and incubated on ice for 20 min. Solubilized proteins were clarified by centrifugation (20 min at 4 C, 13.000 rpm) and protein concentration in lysates was determined using the Bradford assay. To detect phospho-myosin light chains, the lysis buffer contained 0.2 mM of sodium orthovanadate, and transfer was onto PVDF membranes pre-activated by immersion methanol (100%) 1 min at RT, and then incubated, like the gels, in transfer buffer (Tris-glycine-methanol) for 10 min at RT. After transfer, PVDF membranes were blocked with 3% BSA in TBS-T (1 hr RT). b-tubulin was used for protein loading normalization in immunoblots, and numbers below blots indicate quantification of a representative blot by densitometry. Numbers on the left of immunoblots indicate migration of molecular size markers (kDa).
Transepithelial electrical resistance (TEER) and paracellular flux assays For TEER measurements, 2x10 4 cells were plated into 6.5 mm Transwell filters (0.2 mL of medium in the apical compartment and 0.7 mL in the basal compartment), and allowed to grow for 7 days, changing the medium every 2 days, to reach steady-state TEER [7] . Cells were washed with PBS and preincubated for 20 min in Hank's Buffer (HBSS, Invitrogen 14025), containing Ca 2+ and Mg 2+ . Filters were changed into fresh HBSS with vehicle (DMSO) or blebbistatin (100 mM) and incubated for 2 hr at 37 C. TEER was measured using a Millipore ERS-CELL voltmeter. For flux assays, confluent monolayers in duplicate 6.5 mm Transwell filters were cultured in normal medium for 24 hr, washed with HBSS, and incubated in HBSS containing either vehicle (DMSO), or blebbistatin (100 mM in DMSO) for 2 hr at 37 C. The buffer in the apical chamber was removed, the filter transferred into a new well, and 0.2 mL Hanks' Buffer, containing 50 mL 3 kDa FITC-Dextran 1 mg/mL (Invitrogen D3305, stock 10 mg/mL) was added to the apical compartment. After incubation at 37 C for 3 hr, 0.1 mL of the basal compartment medium was removed, and fluorescence was measured with a spectrophotometer (l = 521 nm). The apparent permeability to FITC-Dextran was calculated using the formula: P app = (ng/mL basal) x 10 6 /Area well x Initial concentration x Time (sec) [7] .
Proximity Ligation Assay (PLA) Proximity ligation assay (Sigma, catalog n. DUO92101) was carried out according to the manufacturer's instructions, using antibodies against phospho-Histone H3, myc, HA, ZO-1, occludin (Key Resources Table) . Quantification of signals was carried out using ImageJ.
Structured Illumination Microscopy (SIM)
Eph4 ZO1-KO cells expressing the exogenous myc-ZO1-HA were plated on refractive index-adapted glass coverslips (Carl Roth, D-76185) in 12-well plates for 24 hr, transfected either with si-control or si-ZO-2, and incubated for further 48 hr. Following treatment either with DMSO or blebbistatin cells were fixed with cold methanol and double stained with antibodies against myc and HA, followed by Cy-3 and Alexa488-labeled secondary antibodies. Cells stably expressing GFP-cingulin-myc were plated on refractive index-adapted glass coverslips, and cultured for 72 hr, and double stained with antibodies against GFP and myc. Coverslips were mounted with Fluoromount-G (Southern Biotech 0100-01). Structured illumination images were acquired using a Nikon SIM setup (Eclipse T1) microscope fitted with a Plan Apochromat TIRF 100X, 1.49 NA objective and an electron-multiplying charge-coupled device camera (IXON3; Andor Technology). Z stack acquisition of 31 to 80 sections of 120 nm step was performed in 3D SIM acquisition mode (15 images per plane; five phases of three rotations) with an 80 ms-exposure time, using a 488-nm Coherent sapphire laser at 0,87 mW; 200 -ms exposure time using a 561-nm Cobolt Laser at 0,23 mW, and a 50-ms exposure using a Coherent 640nm Cobolt Laser at 0,37 mW (measured in the back focal plane of the objective). Multicolor 100 nm TetraSpeck Fluorescent Microspheres (blue/green/orange/dark red, Thermofisher, T7279) were used for calibration of red-green chromatic shift. To acquire simultaneous images of cells plus microspheres (beads), Z stack acquisition was performed on 31 to 80 sections, and the 640 nm channel (far-red) only labeled the beads. Image reconstruction and processing were performed using the NIS-Elements software. Reconstruction parameters were as follows: Illumination Modulation Contrast 0.70-0.80; High Resolution Noise Suppression 0-5-1.00; and Section out of Focus Blur Suppression 0.50. The reconstruction parameter for the Z stack 3D SIM were as follows: Illumination Modulation Contrast 0.80; and High Resolution Noise Suppression 0.80. Linescan-Analysis (ImageJ) was carried out on a 400 nm linear distance across the junction, centering on the maximum intensity signal. Using the Plot-Profile plugin of ImageJ pixel intensities (y axis) of red and green fluorophores were plotted as a function of distance (x axis) across the junction. The x-coordinate of the maximum intensity peak was determined using the mean function of the Gaussian curve (Prism software). The calculated distances were 71 ± 8.5 nm (control siRNA), 75.1 ± 3.2 nm (control siRNA + blebbistatin), 74.9 ± 7.8 nm (siZO-2), and 1.2 ± 0.5 nm (si ZO-2 + blebbistatin). Using the MAX function of Excel to calculate the distance between the X-coordinates gave approximately 30% higher values (e.g., z100 nm for the stretched conformation of ZO-1). For each experimental condition, data were obtained from two independent experiments, and in each experiment 5 junctional areas were examined in each of three separate cells.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data processing and analysis were performed in GraphPad Prism 7. All experiments were carried out at least in triplicate, and data are shown either as dot-plots (raw data, with mean and standard deviation indicated) or as histograms (mean, with bars indicating standard deviation). Statistical significance of quantitative data was determined by unpaired two-tailed Student's t test (*p % 0.5, **p % 0.01, ***p % 0.001,**** p % 0.0001), assuming the hypotheses of this test are met.
Analysis of immunofluorescence and immunoblotting data
For the quantification of junctional immunofluorescent signal, pixel intensity for each channel was measured in the selected junctional area using the polyhedral tool of ImageJ, and the averaged background signal of the image was subtracted. Relative signal was expressed as a ratio between the protein of interest and an internal junctional reference (either PLEKHA7 in Figure 3C or E-cadherin in Figure S4G ). For each experimental condition, one replicate, i.e., each dot of dot-plots, represents the average of 3 images (n = 6 for each condition). For the quantification of immunoblot signals, densitometric analysis was carried out and the signal was normalized to tubulin, used as reference for total protein loading ( Figures 3D, 5F , 6E, 6H, 6I, and S6E). For immunoblots in Figures 3H, 4B ', 6B', and S4I, each histogram represents the mean of 3 densitometric analyses carried out on 3 independent experimental repeats (n = 3).
Where indicated by numbers below immunoblot, one representative blot is shown.
Analysis of SIM data
For SIM experiments, the distribution plot (Gaussian curves in Figure 1H and Figures S1C and S1E) was established with the measured fluorescent intensities carried out on 5 different junctional segments of the same cell. In dot-plots ( Figure 1I and Figure S1F ), for each experimental condition, each replicate corresponds to the mean of the Gaussian curve established with 5 junctional areas of one cell (n = 5).
Analysis of proliferation data
For proliferation assays in 2D, each dot represents the calculated percentage of Ki67-positive cells in a field containing on average 50 cells (n = 20 fields in total for each experimental condition, done in 4 experiments, Figure 4A ). For proliferation assays in 3D ( Figure S4E ), histograms show the percentage of Ki67-positive cells out of 100 (n = 3). For analysis of cyst size, data are from 30 cysts (n = 30, Figure 5A ). For the calculation of cell numbers (DAPI staining), in each of the 3 experiments (n = 3), 5 fields of cells, containing on average 20 cells each (total = 100 cells for each experimental condition), were considered ( Figure S4F ).
Analysis of qRT-PCR data
For qRT-PCR, each dot corresponds to the mean of triplicates coming from one RNA extraction normalized to the expression of HPRT gene (internal reference) (n = 3, Figures 4C and 4D ).
Analysis of permeability data
For permeability assays, 6 values (n = 6) were measured in 3 separate experiments for transepithelial electrical resistance ( Figure 4E ) and for permeability to 3 kDa FITC dextran ( Figure 4F ).
